Industry
Biotechnology
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Loading...
Open
5.94
Mkt cap
37M
Volume
39K
High
6.04
P/E Ratio
-0.35
52-wk high
28.68
Low
5.74
Div yield
N/A
52-wk low
4.11
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.